249 related articles for article (PubMed ID: 19417630)
21. Carbon monoxide releasing molecule-2 increases fibrinogen-dependent coagulation kinetics but does not enhance prothrombin activity.
Nielsen VG; Malayaman SN; Khan ES; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2010 Jun; 21(4):349-53. PubMed ID: 20449889
[TBL] [Abstract][Full Text] [Related]
22. Carbon monoxide-releasing molecule-2 enhances coagulation and diminishes fibrinolytic vulnerability in diluted plasma in vitro.
Nielsen VG; Green P; Green M; Martin-Ross A; Khan ES; Kirklin JK; George JF
J Trauma; 2011 Apr; 70(4):939-47. PubMed ID: 20693919
[TBL] [Abstract][Full Text] [Related]
23. Contact activation prolongs clot lysis time in human plasma: role of thrombin-activatable fibrinolysis inhibitor and Factor XIII.
Nielsen VG; Steenwyk BL; Gurley WQ
J Heart Lung Transplant; 2006 Oct; 25(10):1247-52. PubMed ID: 17045938
[TBL] [Abstract][Full Text] [Related]
24. Thrombelastographic method to quantify the contribution of factor XIII to coagulation kinetics.
Nielsen VG; Kirklin JK; Hoogendoorn H; Ellis TC; Holman WL
Blood Coagul Fibrinolysis; 2007 Mar; 18(2):145-50. PubMed ID: 17287631
[TBL] [Abstract][Full Text] [Related]
25. Effects of aprotinin on plasma coagulation kinetics determined by thrombelastography: role of Factor XI.
Nielsen VG
Acta Anaesthesiol Scand; 2006 Feb; 50(2):168-72. PubMed ID: 16430537
[TBL] [Abstract][Full Text] [Related]
26. Carbon Monoxide-Releasing Molecule Enhances Coagulation and Decreases Fibrinolysis in Normal Canine Plasma.
Donaghy D; Yoo S; Johnson T; Nielsen V; Olver C
Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):257-262. PubMed ID: 29577635
[TBL] [Abstract][Full Text] [Related]
27. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma.
Nielsen VG
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):191-6. PubMed ID: 19657316
[TBL] [Abstract][Full Text] [Related]
28. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule.
Clark JE; Naughton P; Shurey S; Green CJ; Johnson TR; Mann BE; Foresti R; Motterlini R
Circ Res; 2003 Jul; 93(2):e2-8. PubMed ID: 12842916
[TBL] [Abstract][Full Text] [Related]
29. The impact of tissue factor pathway inhibitor on coagulation kinetics determined by thrombelastography.
Audu P; Nielsen VG; Armstead V; Powell G; Kim J; Kim L; Mehta M
Anesth Analg; 2006 Oct; 103(4):841-5. PubMed ID: 17000790
[TBL] [Abstract][Full Text] [Related]
30. Carbon monoxide protects against ischemia-reperfusion injury in an experimental model of controlled nonheartbeating donor kidney.
Bagul A; Hosgood SA; Kaushik M; Nicholson ML
Transplantation; 2008 Feb; 85(4):576-81. PubMed ID: 18347537
[TBL] [Abstract][Full Text] [Related]
31. Effect of Iron and Carbon Monoxide on Fibrinogenase-like Degradation of Plasmatic Coagulation by Venoms of Six Agkistrodon Species.
Nielsen VG; Redford DT; Boyle PK
Basic Clin Pharmacol Toxicol; 2016 May; 118(5):390-5. PubMed ID: 26467642
[TBL] [Abstract][Full Text] [Related]
32. [Study of exogenous carbon monoxide-releasing molecules 2 on endotoxin/lipopolysaccharide-induced abnormal activation of platelets of healthy human donors].
Liu D; Zhuang M; Zhang J; Chen J; Sun B
Zhonghua Shao Shang Za Zhi; 2015 Oct; 31(5):354-60. PubMed ID: 26714404
[TBL] [Abstract][Full Text] [Related]
33. Iron and carbon monoxide attenuate degradation of plasmatic coagulation by Crotalus atrox venom.
Nielsen VG; Boyer LV
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):506-10. PubMed ID: 26575491
[TBL] [Abstract][Full Text] [Related]
34. Cell damage following carbon monoxide releasing molecule exposure: implications for therapeutic applications.
Winburn IC; Gunatunga K; McKernan RD; Walker RJ; Sammut IA; Harrison JC
Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):31-41. PubMed ID: 22269084
[TBL] [Abstract][Full Text] [Related]
35. Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3).
Musameh MD; Green CJ; Mann BE; Fuller BJ; Motterlini R
J Heart Lung Transplant; 2007 Nov; 26(11):1192-8. PubMed ID: 18022087
[TBL] [Abstract][Full Text] [Related]
36. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions.
Nielsen VG
Acta Anaesthesiol Scand; 2005 Oct; 49(9):1263-71. PubMed ID: 16146462
[TBL] [Abstract][Full Text] [Related]
37. Crotalus atrox Venom Exposed to Carbon Monoxide Has Decreased Fibrinogenolytic Activity In Vivo in Rabbits.
Nielsen VG
Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):82-86. PubMed ID: 28691277
[TBL] [Abstract][Full Text] [Related]
38. Iron and carbon monoxide prevent degradation of plasmatic coagulation by thrombin-like activity in rattlesnake venom.
Nielsen VG
Hum Exp Toxicol; 2016 Oct; 35(10):1116-22. PubMed ID: 26666988
[TBL] [Abstract][Full Text] [Related]
39. Investigation into the mechanism(s) of antithrombotic effects of carbon monoxide releasing molecule-3 (CORM-3).
Soni H; Jain M; Mehta AA
Thromb Res; 2011 Jun; 127(6):551-9. PubMed ID: 21376373
[TBL] [Abstract][Full Text] [Related]
40. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
